NCT07444437 A Phase II Trial of LM103 for Adjuvant Treatment in Patients With Non-small Cell Lung Cancer Status RECRUITING Phase PHASE2
NCT07442565 SYS6010 Versus Docetaxel for Previously Treated EGFR Wild-type NSCLC: Phase Ⅲ Status NOT_YET_RECRUITING Phase PHASE3
NCT07439094 A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT07432308 Liquid Biopsy Genotyping Using Oncomine Precision Assay GX in Advanced NSCLC Status COMPLETED Phase NA
NCT07431827 MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013) Status RECRUITING Phase PHASE3
NCT07428044 A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE2
NCT07423117 A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy Status NOT_YET_RECRUITING Phase PHASE1
NCT07418879 A Real-world Study of Pralsetinib Combined With Leucogen in the Treatment of RET Fusion-positive NSCLC Status NOT_YET_RECRUITING Phase NA
NCT07416994 Pivotal Study to Evaluate YL202 Versus Docetaxel in Patients With Locally Advanced or Metastatic EGFR Sensitive Mutation Non-Squamous Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE3
NCT07416474 RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC) Status RECRUITING Phase PHASE3
NCT07412262 A Study of Chidamide Combined With Ivonescimab in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) With Acquired Resistance to Immunotherapy and High Yes-associated Protein (YAP) Expression Status NOT_YET_RECRUITING Phase PHASE2
NCT07412041 Precise Exercise Regimen for Cancer Care (PERCC): A Pilot Study Status RECRUITING Phase NA
NCT07401056 Preoperative Structured Exercise Programme on Patients With Non-Small Cell Lung Cancer Status NOT_YET_RECRUITING Phase NA
NCT07392073 Peripheral Blood ETASTs for Predicting Efficacy of Chemoimmunotherapy in NSCLC Status NOT_YET_RECRUITING Phase N/A
NCT07383454 Lung Cancer Screening in Population Who Had Never Smoked Status NOT_YET_RECRUITING Phase NA
NCT07382726 Phase 1 Study Of Izalontamab Brengitecan + Adagrasib In NSCLC - The IZA-A Trial Status RECRUITING Phase PHASE1
NCT07377916 Clinical Study of SHR-A1811 Combined With Pertuzumab as Second-Line Therapy in Patients With HER2-Altered Advanced NSCLC Status NOT_YET_RECRUITING Phase NA